Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis
- PMID: 19501022
- DOI: 10.1016/S1474-4422(09)70126-7
Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis
Abstract
Background: In a systematic review, published in 1997, we found that the case fatality of aneurysmal subarachnoid haemorrhage (SAH) decreased during the period 1960-95. Because diagnostic and treatment strategies have improved and new studies from previously non-studied regions have been published since 1995, we did an updated meta-analysis to assess changes in case fatality and morbidity and differences according to age, sex, and region.
Methods: A new search of PubMed with predefined inclusion criteria for case finding and diagnosis identified reports on prospective population-based studies published between January, 1995, and July, 2007. The studies included in the previous systematic review were reassessed with the new inclusion criteria. Changes in case fatality over time and the effect of age and sex were quantified with weighted linear regression. Regional differences were analysed with linear regression analysis, and the regions of interest were subsequently defined as reference regions and compared with the other regions.
Findings: 33 studies (23 of which were published in 1995 or later) were included that described 39 study periods. These studies reported on 8739 patients, of whom 7659 [88%] were reported on after 1995. 11 of the studies that were included in the previous review did not meet the current, more stringent, inclusion criteria. The mean age of patients had increased in the period 1973 to 2002 from 52 to 62 years. Case fatality varied from 8.3% to 66.7% between studies and decreased 0.8% per year (95% CI 0.2 to 1.3). The decrease was unchanged after adjustment for sex, but the decrease per year was 0.4% (-0.5 to 1.2) after adjustment for age. Case fatality was 11.8% (3.8 to 19.9) lower in Japan than it was in Europe, the USA, Australia, and New Zealand. The unadjusted decrease in case fatality excluding the data for Japan was 0.6% per year (0.0 to 1.1), a 17% decrease over the three decades. Six studies reported data on case morbidity, but these were insufficient to assess changes over time.
Interpretation: Despite an increase in the mean age of patients with SAH, case-fatality rates have decreased by 17% between 1973 and 2002 and show potentially important regional differences. This decrease coincides with the introduction of improved management strategies.
Funding: Netherlands Organisation for Scientific Research; ZonMw.
Comment in
-
Case fatality after subarachnoid haemorrhage: declining, but why?Lancet Neurol. 2009 Jul;8(7):598-9. doi: 10.1016/S1474-4422(09)70143-7. Epub 2009 Jun 6. Lancet Neurol. 2009. PMID: 19501023 No abstract available.
Similar articles
-
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review.Stroke. 1997 Mar;28(3):660-4. doi: 10.1161/01.str.28.3.660. Stroke. 1997. PMID: 9056628
-
Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS).Stroke. 2000 Aug;31(8):1843-50. doi: 10.1161/01.str.31.8.1843. Stroke. 2000. PMID: 10926945
-
Case fatality and functional outcome after spontaneous subarachnoid haemorrhage: A systematic review and meta-analysis of time trends and regional variations in population-based studies.Eur Stroke J. 2024 Sep;9(3):555-565. doi: 10.1177/23969873241232823. Epub 2024 Feb 14. Eur Stroke J. 2024. PMID: 38353205 Free PMC article.
-
Incidence and case fatality of subarachnoid haemorrhage in Northern Greece: the Evros Registry of Subarachnoid Haemorrhage.Int J Stroke. 2009 Oct;4(5):322-7. doi: 10.1111/j.1747-4949.2009.00334.x. Int J Stroke. 2009. PMID: 19765118
-
Incidence, treatment, and case-fatality of non-traumatic subarachnoid haemorrhage in the Netherlands.Clin Neurol Neurosurg. 2011 Jul;113(6):483-7. doi: 10.1016/j.clineuro.2011.02.015. Epub 2011 Mar 21. Clin Neurol Neurosurg. 2011. PMID: 21420782
Cited by
-
Association between three eNOS polymorphisms and intracranial aneurysms risk: a meta-analysis.Medicine (Baltimore). 2015 Jan;94(4):e452. doi: 10.1097/MD.0000000000000452. Medicine (Baltimore). 2015. PMID: 25634184 Free PMC article. Review.
-
Elevated Red Cell Distribution Width is Associated with Cerebral Infarction in Aneurysmal Subarachnoid Hemorrhage.Neurocrit Care. 2017 Feb;26(1):26-33. doi: 10.1007/s12028-016-0306-2. Neurocrit Care. 2017. PMID: 27530692
-
The location of intraparenchymal bleeding determines functional outcome after spontaneous subarachnoid hemorrhage.Eur J Neurol. 2023 Feb;30(2):372-379. doi: 10.1111/ene.15621. Epub 2022 Nov 21. Eur J Neurol. 2023. PMID: 36318275 Free PMC article.
-
Adverse events during endovascular treatment of ruptured aneurysms: A prospective nationwide study on subarachnoid hemorrhage in Sweden.Brain Spine. 2023 Nov 10;3:102708. doi: 10.1016/j.bas.2023.102708. eCollection 2023. Brain Spine. 2023. PMID: 38021017 Free PMC article.
-
A randomized, single ascending dose safety, tolerability and pharmacokinetics study of NicaPlant® in aneurysmal subarachnoid hemorrhage patients undergoing clipping.Brain Spine. 2023 Sep 18;3:102673. doi: 10.1016/j.bas.2023.102673. eCollection 2023. Brain Spine. 2023. PMID: 38021019 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical